TCGX Acquisition Corp. II Closes $100M IPO, $4.5M Sponsor Placement and $20M Forward Purchase
TCXB is trading near its 52-week low of $10.335 (0.6% above the low) on light trading volume (0.3× avg).
Summary
TCGX Acquisition Corp. II closed its $100 million IPO at $10.00 per share, with $100 million in trust, a $4.5 million sponsor private placement and a conditional $20 million forward purchase tied to a future business combination.
Key Events · Financing and Capital Events · TCXB
-
IPO Closes With $100M in Trust
10,000,000 Class A ordinary shares sold at $10.00 per share for $100,000,000 gross proceeds, all deposited in a U.S. trust account at Citibank, N.A. with Odyssey Transfer and Trust Company as trustee.
-
Sponsor Buys $4.5M Private Placement
TCGX Sponsor II, LLC purchased 450,000 Class A shares at $10.00 for $4,500,000 in a private sale exempt under Section 4(a)(2), with no underwriting discounts.
-
Conditional $20M Forward Purchase
TCG Crossover Fund III, LP committed to buy 2,000,000 Class A shares at $10.00 for $20,000,000, but only at the business combination closing and only after its investment committee approves the deal.
-
Two-Year Deadline to Find Target
If no business combination closes within 24 months of the IPO, the trust liquidates and redeems 100% of public shares; the company targets healthcare, life sciences and medical technology.
Analysis · TCXB · Technology
The blank-check IPO is now funded: $100 million sits in trust at $10.00 per share, plus $4.5 million from the sponsor's private placement, giving the company roughly two years to find and close a healthcare or life-sciences acquisition. The $20 million forward purchase from TCG Crossover Fund III is a conditional backstop, not committed cash — it only funds at the business combination closing and only if the fund's investment committee approves the deal first, so it cannot be counted on until a target is signed. No warrants were issued, so public holders get only the trust value and redemption right, with no upside kicker. The board is now three independent directors in staggered classes after the two pre-IPO directors stepped down.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 29.4% of the 1386 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TCXB was trading at $10.40 on NASDAQ in the Technology sector, with a market capitalization of approximately $108.7M. The 52-week trading range was $10.34 to $11.74. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.